Crosscheck

Your medical. Crosschecked.

Skin

Triamcinolone (topical)

Corticosteroid, topical
Other names: Oralone, Triderm, Aristocort A, Kenacort

FAA guidance

Acceptable in the FAA document cited.

Source: FAA, MedGuide (FAA Office of Aerospace Medicine medication reference). FAA date 1 October 2026. Checked by Crosscheck 14 October 2026

The FAA's MedGuide lists triamcinolone (topical) (Oralone, Triderm, Aristocort A, Kenacort) as allowed, for dermatitis (Allergic/Atopic), with no wait after the first dose, after later doses or after the final dose, used as prescribed.

Track your medications
More detail: triamcinolone (topical)The rest of Crosscheck's reading, in plain wordsOpen

The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.

Show the FAA's words: triamcinolone (topical)The official FAA wording: three passages, each with its document and dateOpen
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Generic: triamcinolone (topical)
Brand Name: Oralone; Triderm; Aristocort A [INTL]; Kenacort [INTL]
Drug Class: Corticosteroid, topical
Underlying Condition: Dermatitis (Allergic/Atopic)
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.
Sources and dates: triamcinolone (topical)One FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.